In recent 20 years, the global industrial biotechnology industry has developed rapidly, especially the bio-manufacturing industry of biomedicine and bulk chemicals. According to statistics, the global biomedical industry will maintain an annual growth rate of more than 13.5% from 2010…
Zhejiang Jinyi Shengshi Bioengineering Co., Ltd. (hereinafter referred to as “the company” or ” JYSS BIO”), a single-use system provider for biopharmaceuticals, recently completed a B+ round of financing of several hundred million Renminbi, which was jointly led by Huatai…
More than 3 years after the outbreak of the COVID-19, the situation is still severe, but the proportion of asymptomatic infections in domestic confirmed cases has risen significantly to 92%-95%, which is related to the high vaccination rate in China.…
Recently, the U.S. Department of Commerce’s Bureau of Industry and Security (BIS) posted a new batch of “Unverified Lists (UVLs)” online. In this “Unverified List (UVL)”, 33 Chinese companies have been added, and Chinese well-known CDMO companies are on the…